Abstract
A series of compounds containing an α,β-unsaturated carbonyl moiety, such as chalcones and coumarins were designed, synthesized and tested in a variety of assays to assess their potential as anti-Alzheimer's disease (AD) agents. The investigations included the inhibition of cholinesterases (AChE, BuChE), the inhibition of amyloid beta (Aβ) self-assembly and the disassembly of preformed Aβ oligomers. Several compounds showed excellent potential as multifunctional compounds for AD. Docking studies for 16 that performed well in all the assays gave a clear interpretation of various interactions in the gorge of AChE. Based on the results, the long-chain coumarin scaffold appears to be a promising structural template for further AD drug development.
Original language | English |
---|---|
Pages (from-to) | 2614-2618 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 23 |
Issue number | 9 |
DOIs | |
State | Published - May 1 2013 |
Bibliographical note
Funding Information:Financial support provided by the University of Massachusetts Boston, and National Institute of Health ( R-15 AG025777-03A1 and R21AG028816-01 to H.L.) is gratefully acknowledged.
Keywords
- Alzheimer's disease
- Amyloid beta
- Chalcones
- Cholinesterase inhibition
- Coumarins
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry